Literature DB >> 15035362

Characterization of colicinogenic Escherichia coli strains inhibitory to enterohemorrhagic Escherichia coli.

Gerry P Schamberger1, Francisco Diez-Gonzalez.   

Abstract

A previously identified set of anti-Escherichia coli O157:H7 colicinogenic E. coli were characterized to assess the suitability of these isolates as a preharvest food safety intervention in cattle. This collection of 23 E. coli strains were screened for virulence factors, antibiotic resistance, type of colicin(s) present, and their ability to inhibit other pathogenic E. coli. With the use of PCR, pathogen genes were detected in six of the 23 colicinogenic E. coli. When the nonpathogenic strains were assessed for antibiotic resistance, four strains showed resistance to at least one antibiotic. The remaining set of 14 strains were evaluated for the presence of previously identified colicins. Seven colicins (B, El, E2/E7, E7, Ia/Ib, K, and M) were detected. One half of the strains possessed multiple types of colicins. The most commonly detected colicins were B, E2/E7, and M, which were found in six strains each. DNA sequencing was also performed in order to classify the E2/E7 colicins separately from E7 colicins. The 14 colicinogenic E. coli also were evaluated for their ability to inhibit 10 different non-O157 pathogenic E. coli. Six of the colicinogenic E. coli were capable of inhibiting all 10 pathogens, and the remaining eight strains could each inhibit between six to eight of the pathogenic E. coli. This strain collection has great potential for inhibiting E. coli O157:H7 in cattle.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15035362     DOI: 10.4315/0362-028x-67.3.486

Source DB:  PubMed          Journal:  J Food Prot        ISSN: 0362-028X            Impact factor:   2.077


  15 in total

Review 1.  Bacteriocin production: a probiotic trait?

Authors:  Alleson Dobson; Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Appl Environ Microbiol       Date:  2011-10-28       Impact factor: 4.792

2.  Prevalence of ColE1-like plasmids and colicin K production among uropathogenic Escherichia coli strains and quantification of inhibitory activity of colicin K.

Authors:  Matija Rijavec; Maruska Budic; Peter Mrak; Manica Müller-Premru; Zdravko Podlesek; Darja Zgur-Bertok
Journal:  Appl Environ Microbiol       Date:  2006-11-22       Impact factor: 4.792

3.  Accumulation of single-stranded DNA in Escherichia coli carrying the colicin plasmid pColE3-CA38.

Authors:  Magali Morales; Hedieh Attai; Kimberly Troy; David Bermudes
Journal:  Plasmid       Date:  2014-11-05       Impact factor: 3.466

4.  Prevalence of enteric bacteria that inhibit growth of enterohaemorrhagic Escherichia coli O157 in humans.

Authors:  H Toshima; M Hachio; Y Ikemoto; J Ogasawara; A Hase; K Takahashi; H Masaki; Y Nishikawa
Journal:  Epidemiol Infect       Date:  2006-06-02       Impact factor: 2.451

Review 5.  The dual role of bacteriocins as anti- and probiotics.

Authors:  O Gillor; A Etzion; M A Riley
Journal:  Appl Microbiol Biotechnol       Date:  2008-10-14       Impact factor: 4.813

6.  Reduction of Escherichia coli O157:H7 populations in cattle by addition of colicin E7-producing E. coli to feed.

Authors:  Gerry P Schamberger; Ronald L Phillips; Jennifer L Jacobs; Francisco Diez-Gonzalez
Journal:  Appl Environ Microbiol       Date:  2004-10       Impact factor: 4.792

7.  Genotypic characterization and prevalence of virulence factors among Canadian Escherichia coli O157:H7 strains.

Authors:  Kim Ziebell; Marina Steele; Yongxiang Zhang; Andrew Benson; Eduardo N Taboada; Chad Laing; Scott McEwen; Bruce Ciebin; Roger Johnson; Victor Gannon
Journal:  Appl Environ Microbiol       Date:  2008-05-16       Impact factor: 4.792

Review 8.  Regulation of bacterial pathogenesis by intestinal short-chain Fatty acids.

Authors:  Yvonne Sun; Mary X D O'Riordan
Journal:  Adv Appl Microbiol       Date:  2013       Impact factor: 5.086

9.  Enhancement of Shiga toxin production in enterohemorrhagic Escherichia coli serotype O157:H7 by DNase colicins.

Authors:  Hirono Toshima; Ayana Yoshimura; Kentaro Arikawa; Ayumi Hidaka; Jun Ogasawara; Atsushi Hase; Haruhiko Masaki; Yoshikazu Nishikawa
Journal:  Appl Environ Microbiol       Date:  2007-10-12       Impact factor: 4.792

10.  Escherichia coli bacteriocins: antimicrobial efficacy and prevalence among isolates from patients with bacteraemia.

Authors:  Maruška Budič; Matija Rijavec; Ziva Petkovšek; Darja Zgur-Bertok
Journal:  PLoS One       Date:  2011-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.